EXOZYMES director Bowie receives 10,000 stock options

Q: How many options did EXOZ director James Ulrich Bowie receive?

James Ulrich Bowie received an option award covering 10,000 shares of common stock on October 1, 2026. The option has an exercise price of $6.28 per share.

Q: How does James Ulrich Bowie's EXOZ option vest?

The option vests in 12 quarterly installments, beginning December 31, 2026, and ending September 30, 2029, subject to the reporting person's continued service with the issuer. Eleven installments are 833 shares each, and the final installment is 837 shares.

The director's option vests in quarterly installments through September 30, 2029, subject to continued service with the issuer.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

EXOZYMES INC. director James Ulrich Bowie received an option award covering 10,000 shares of common stock on October 1, 2026. The option has an exercise price of $6.28 per share and expires October 1, 2033. It vests in 12 quarterly installments, beginning December 31, 2026, and ending September 30, 2029, subject to continued service with the issuer. Bowie reported direct ownership of 577,910 common shares on October 1, 2026.

Insider Trade Summary

Grant/Award: 10,000 shares

Grant/Award 2 txns

Insider Bowie James Ulrich

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) ^F1	10,000	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 10,000 contracts (Direct); Common Stock — 577,910 shares (Direct)

Footnotes (1)

F1. The option vests in twelve (12) quarterly installments, consisting of eleven (11) installments of 833 shares and a final installment of 837 shares, beginning on 12/31/2026 and ending on 09/30/2029, subject to the reporting person's continued service with the issuer. The option expires on 10/01/2033.

Key Figures

Option award shares: 10,000 shares Exercise price: $6.28 per share Direct common shares owned: 577,910 shares +4 more

7 metrics

Option award shares 10,000 shares Option award dated October 1, 2026

Exercise price $6.28 per share Option award dated October 1, 2026

Direct common shares owned 577,910 shares Reported on October 1, 2026

Quarterly vesting installments 12 installments Vesting begins December 31, 2026, and ends September 30, 2029

Shares in each of the first eleven installments 833 shares Option vesting schedule

Shares in final installment 837 shares Option vesting schedule

Option expiration October 1, 2033 Option award

Key Terms

Stock Option (right to buy), vests, quarterly installments

3 terms

Stock Option (right to buy) financial

"Stock Option (right to buy)"

vests financial

"The option vests in twelve (12) quarterly installments"

quarterly installments financial

"twelve (12) quarterly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did EXOZ director James Ulrich Bowie receive?

James Ulrich Bowie received an option award covering 10,000 shares of common stock on October 1, 2026. The option has an exercise price of $6.28 per share.

How does James Ulrich Bowie's EXOZ option vest?

The option vests in 12 quarterly installments, beginning December 31, 2026, and ending September 30, 2029, subject to the reporting person's continued service with the issuer. Eleven installments are 833 shares each, and the final installment is 837 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/19/2026 - 07:47 PM EDT Accepted by SEC EDGAR 10/19/2026 - 07:46 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bowie James Ulrich

(Last)

(First)

(Middle)

C/O 750 ROYAL OAKS DRIVE, SUITE 106

(Street)

MONROVIA

CALIFORNIA

91016

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXOZYMES INC. [ EXOZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								577,910	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$6.28	10/01/2026		A		10,000		⁽¹⁾	10/01/2033	Common Stock	10,000	$0.00	10,000	D

Explanation of Responses:

1. The option vests in twelve (12) quarterly installments, consisting of eleven (11) installments of 833 shares and a final installment of 837 shares, beginning on 12/31/2026 and ending on 09/30/2029, subject to the reporting person's continued service with the issuer. The option expires on 10/01/2033.

	/s/ James U. Bowie	10/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR